OG DNA Genetics Inc.(DNA) and Generic Gold Corporation (Generic Gold) announced that they have entered into a definitive agreement to complete their previously announced business combination. Upon completion of the Proposed Transaction, the security holders of DNA will hold substantially all of the outstanding securities of Generic Gold (the "Resulting Issuer"), and the Resulting Issuer will carry on the business of DNA. Following the closing of the Proposed Transaction, it is anticipated that the Resulting Issuer will be led by Charles Phillips, Chief Executive Officer, Don Morris, Chief Cannabis Officer and Aaron Yarkoni, Chief Research Officer.